Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Acta Neurologica Scandinavica|September 17, 2013
Dependent and paranoid personality patterns in myotonic dystrophy type 1S Peric, M Sreckov, I Basta, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 25, 2020
Prospective analysis of gait characteristics in chronic inflammatory demyelinating polyradiculoneuropathyI Bozovic, S Peric, I Basta, et al.Clinical Neurology and Neurosurgery|June 15, 2012
Influence of multisystemic affection on health-related quality of life in patients with myotonic dystrophy type 1S Peric, V Rakocevic Stojanovic, I Basta, et al.Acta Neurologica Scandinavica|December 17, 2009
Validation of Serbian version of the disease-specific myasthenia gravis questionnaireI Basta, T Pekmezović, L Padua, et al.Acta Neurologica Scandinavica|March 3, 2005
Cyclosporine in the treatment of myasthenia gravisD Lavrnic, A Vujic, V Rakocevic-Stojanovic, et al.Acta Neurologica Scandinavica|October 4, 2016
Five-year study of quality of life in myotonic dystrophyS Peric, M Vujnic, V Dobricic, et al.Neuroepidemiology|February 1, 2013
Epidemiological study of adult-onset myasthenia gravis in the area of Belgrade (Serbia) in the period 1979-2008D Lavrnic, I Basta, V Rakocevic-Stojanovic, et al.Journal of the Neurological Sciences|August 18, 2014
Extrathymic malignancies in a defined cohort of patients with myasthenia gravisI Basta, T Pekmezovic, S Peric, et al.Journal of the Neurological Sciences|June 11, 2011
Cardiac autonomic control in patients with myasthenia gravis and thymomaS Peric, V Rakocevic-Stojanovic, T Nisic, et al.Acta Neurologica Scandinavica|October 7, 2009
Leptin and the metabolic syndrome in patients with myotonic dystrophy type 1V Rakocevic Stojanovic, S Peric, D Lavrnic, et al.Pageof 2